What is cyanosis and what are its causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition and Causes of Cyanosis

Cyanosis is defined as a bluish discoloration of the skin and/or mucous membranes resulting from inadequate oxygenation of the blood, generally requiring at least 5 g/L of unsaturated hemoglobin in tissue to be visible. 1

Definition and Pathophysiology

Cyanosis occurs when there is an increased amount of reduced (deoxygenated) hemoglobin or abnormal hemoglobin in the blood. For cyanosis to be clinically apparent:

  • At least 5 g/L of unsaturated hemoglobin must be present in tissue 1
  • This typically corresponds to oxygen unsaturation of approximately 6-7 volumes percent in the capillaries 2
  • Anemia may result in hypoxemia that does not manifest as cyanosis due to insufficient total hemoglobin 1

Types of Cyanosis

Cyanosis can be classified into two main categories:

1. Central Cyanosis

Results from arterial desaturation due to:

  • Cardiac causes (right-to-left shunting):

    • Congenital heart defects with right-to-left shunting 1
    • Eisenmenger syndrome 1
    • Complex congenital heart disease 1
  • Pulmonary causes:

    • Severe lung diseases affecting gas exchange
    • Ventilation-perfusion mismatch
    • Alveolar hypoventilation
    • High altitude exposure (decreased alveolar oxygen tension) 2
  • Abnormal hemoglobin:

    • Methemoglobinemia (congenital or acquired) 1, 3
      • Type I: CYB5R3 enzyme deficiency (20-30% MetHb levels) 1
      • Type II: Severe form with neurological manifestations 1
    • Hemoglobin M variants (substitution of tyrosine for histidine) 1
    • Sulfhemoglobinemia

2. Peripheral Cyanosis

Results from increased extraction of oxygen from normally saturated arterial blood:

  • Decreased cardiac output:

    • Heart failure
    • Shock
    • Severe dehydration
  • Peripheral vasoconstriction:

    • Cold exposure
    • Acrocyanosis 4
    • Raynaud's phenomenon
    • Peripheral vascular disease
  • Venous stasis:

    • Deep vein thrombosis
    • Venous insufficiency

Secondary Complications of Chronic Cyanosis

Patients with chronic cyanosis develop several adaptive mechanisms and complications:

  1. Hematologic adaptations:

    • Secondary erythrocytosis (increased red cell mass) 1
    • Rightward shift of the oxyhemoglobin dissociation curve 1
    • Increased cardiac output 1
  2. Hematologic complications:

    • Hyperviscosity syndrome (headache, dizziness, fatigue, blurred vision) 1
    • Bleeding diathesis (thrombocytopenia and platelet dysfunction) 1
    • Iron deficiency 1
  3. Systemic complications:

    • Renal dysfunction (abnormal glomeruli, reduced filtration) 1
    • Hyperuricemia and gout 1
    • Gallstones (calcium bilirubinate) 1
    • Orthopedic issues (hypertrophic osteoarthropathy, scoliosis) 1
    • Neurological complications (stroke risk, brain abscess) 1

Diagnostic Approach

When evaluating a cyanotic patient:

  1. Differentiate central from peripheral cyanosis:

    • Central cyanosis affects mucous membranes and warm areas
    • Peripheral cyanosis typically spares mucous membranes
  2. For suspected methemoglobinemia:

    • Measure methemoglobin levels using co-oximetry 1
    • Assess CYB5R enzyme activity
    • Consider genetic testing for congenital forms 1
  3. For suspected cardiac causes:

    • Evaluate oxygen saturation with pulse oximetry
    • Consider arterial blood gas analysis
    • Echocardiography to identify structural heart defects
  4. For chronic cyanosis monitoring:

    • Complete blood count with MCV
    • Iron studies (serum ferritin, transferrin saturation)
    • Renal function tests
    • Uric acid levels 1

Management Considerations

Management depends on the underlying cause, but important principles include:

  • For hyperviscosity symptoms:

    • Therapeutic phlebotomy only if hemoglobin >20 g/dL and hematocrit >65% with symptoms 1
    • Avoid routine phlebotomies due to risk of iron depletion 1
  • For iron deficiency:

    • Cautious iron supplementation with monitoring 1
  • For methemoglobinemia:

    • Specific treatment based on type and severity
  • General measures for chronic cyanosis:

    • Maintain hydration, especially during travel 1
    • Consider supplemental oxygen for long flights 1
    • Avoid high altitudes 1

Understanding the pathophysiology and causes of cyanosis is essential for proper diagnosis and management of this important clinical sign.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

STUDIES ON CYANOSIS : II. SECONDARY CAUSES OF CYANOSIS.

The Journal of experimental medicine, 1919

Research

[Cyanosis in 14-year-old patient. Methemoglobinemia: case report].

Archivos argentinos de pediatria, 2018

Research

Acrocyanosis: an overview.

Indian journal of dermatology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.